Clinical trial
Randomized Embedded Multifactorial Adaptive Platform in ExtraCorporeal Membrane Oxygenation (REMAP ECMO) - Left Ventricular Unloading Study
NCT05913622 is registered in ClinicalTrials.gov with Erasmus Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Randomized Embedded Multifactorial Adaptive Platform in ExtraCorporeal Membrane Oxygenation (REMAP ECMO) - Left Ventricular Unloading Study
- Lead sponsor
- Erasmus Medical Center
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- June 8, 2023
- Completion date
- June 1, 2028
- Enrollment
- 430 (estimated)
- Sites
- 14
Conditions
As the registry lists them; a condition with its own page is linked.
cardiogenic shock